Digital health technology company Eko Health has introduced its next-generation digital stethoscope, the CORE 500.

The new digital stethoscope, which helps improve diagnostic accuracy and provides early disease detection, recently secured 510(k) clearance from the US Food and Drug Administration.

Designed to serve as a critical patient assessment tool for healthcare professionals (HCPs), the stethoscope combines a three-lead electrocardiogram (ECG), a full-colour display, high-fidelity audio experience and artificial intelligence (AI) software.

It offers precise and instantaneous patient auscultation data to HCPs on a full-colour display, including ECG tracing and heart rate.

When supported by the company’s FDA-approved AI products, the stethoscope can detect abnormalities such as tachycardia, bradycardia and atrial fibrillation within seconds.

Compatible with the company’s SENSORA cardiac disease detection platform, the stethoscope is intended for use across clinical specialities, including virtual care, home care, emergency medicine, urgent care, primary care and structural heart.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

SENSORA is an advanced applied machine-learning software, which more than doubles the detection sensitivity of cardiac murmurs indicating structural heart disease.

The stethoscope also integrates with Eko Live Stream for synchronous listening, which enables virtual teams to record, analyse and share auscultation data in real time from anywhere.

Featuring Eko’s new TrueSound audio innovation, the CORE 500 is equipped with up to 40x sound amplification, three audio filter modes and active noise cancellation.

TrueSound has in-ear speaker technology and provides reduced background noise and optimal sound filtering.

Eko Health co-founder and CEO Connor Landgraf said: “The CORE 500 represents a major leap forward in digital stethoscope technology.

“When paired with our powerful AI algorithms, it can help detect leading indicators of heart disease in seconds, greatly assisting healthcare professionals in identifying various cardiac conditions with increased accuracy and confidence.”